22
Last reporting period 31 Dec, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
6.523
Exchange
XHKG - Hong Kong Exchange
11.2 B
Last period Cash and equivalents ,CNY
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also WuXi Biologics
Company Analysis
2269.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
2269.HK financial analysis by Eyestock methodology
Valuation
2269.HK valuation using historical relative method
Statements
2269.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
2269.HK dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
WuXi Biologics`s Cash and equivalents for the period ended 2023-12-31 are 11.2 B CNY
